Home Blog Page 1540

Suvoda sets new standard for streamlined patient and site experience in clinical trials

CONSHOHOCKEN, Pa., Jan. 12, 2026 /PRNewswire/ — Suvoda, a clinical trial technology company, took decisive steps in 2025 toward a more connected and streamlined clinical trial experience for both patients and sites. The company’s merger with Greenphire marked a pivotal moment in that journey, strengthening Suvoda’s ability to tackle persistent trial operational challenges with a more unified approach. Together with continued product innovation and deployment of AI tools, Suvoda closed the year with growing momentum toward a single, cohesive ecosystem that reduces complexity across the clinical trial lifecycle.

“The last twelve months marked an important step forward for Suvoda,” said Jagath Wanninayake, CEO of Suvoda. “Our teams worked with care and intention as we brought two strong companies together and delivered new capabilities that reflect what patients and sites actually need. As we enter 2026, we’re focused on helping sponsors and sites navigate their trials with clarity while giving patients a smoother, more supportive experience.”

Making the patient journey easier

A defining milestone of the year was the launch of Suvoda’s patient app, a clear demonstration of how a unified platform can meaningfully improve the clinical trial experience for patients. The app brings eCOA questionnaires, patient payments, reminders, and visit scheduling into one consumer-grade interface that patients can use on their own devices. This advancement helps participants stay engaged while easing the administrative load for busy sites.

Harnessing AI to alleviate administrative burden in clinical trials

Suvoda also simplified how study teams access critical information with Sofia, an AI assistant currently deployed in Suvoda IRT with platform expansion in the future. Sofia helps users ask questions and get answers with a generative AI tool, replacing multi-step navigation with quick, clear responses. Built with strong privacy and role-based controls, Sofia supports everyday decision making for study teams without compromising data security or the integrity of the study blind.

Recognized for innovation

Suvoda’s approach earned continued recognition in 2025, including a new patent for its platform architecture, bringing its total to five. Everest Group also named Suvoda a Leader in its RTSM PEAK Matrix® assessment. Across its portfolio, Suvoda released enhancements that improve transparency, data quality, and ease of use, reflecting its ongoing focus on practical innovation that supports real-world trial operations.

Positioned for continued growth in 2026

The company anticipates continuing its strong growth in 2026 as pharmaceutical sponsors and CROs increasingly look for unified platforms that reduce trial complexity while supporting exceptional patient and site experiences.

“We spent 2025 not only merging two companies, but unifying our technologies, our people, and our mission,” Wanninayake said. “That foundation positions us to deliver even greater value in 2026 and beyond. We’re ready to support sponsors and sites to meet more of their clinical trial needs and help patients move through their studies with ease and confidence.”

About Suvoda

Suvoda is a global clinical trial technology company with a market-leading, real-time software platform that empowers sponsors and CROs to make confident decisions and sites and patients to take calm, controlled action. Suvoda delivers interconnected, action-driven software solutions and industry-leading services and support, so that even in the most time-sensitive, mission-critical moments, life-changing studies keep moving forward. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company maintains customer satisfaction scores that consistently exceed the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 2000 trials across more than 95 countries. Suvoda recently merged with Greenphire, a leading provider of clinical trial financial management and patient support tools. To learn more, visit suvoda.com and follow Suvoda on LinkedIn.

CONTACT: 
Robin Abadía 
Director, External Communications 
marketing@suvoda.com

Logo – https://laotiantimes.com/wp-content/uploads/2026/01/suvoda_updated_logo.jpg

Basecamp Research launches world-first AI models for programmable gene insertion

  • The breakthrough tackles a longstanding challenge in genetic medicine with the goal of developing a new generation of curative cell and gene therapies.
  • Developed in collaboration with NVIDIA by training the largest evolutionary AI models on a new, globally collected dataset, accelerated by NVIDIA BioNeMo.
  • The same versatile model also helped design novel antimicrobial peptide molecules with a 97% lab-confirmed success rate, including candidates that appeared highly potent against multidrug-resistant “superbugs.”
  • Basecamp Research also adds NVentures as an investor ahead of Series C round following deep technical collaboration on EDEN models.

LONDON and CAMBRIDGE, Mass., Jan. 12, 2026 /PRNewswire/ — Basecamp Research, a frontier AI lab harnessing evolution to design new medicines, today announced the first AI models capable of programmable gene insertion, offering a new way to replace faulty genes and reprogram cells for therapeutic use. Trained in collaboration with NVIDIA, these models are driving the development of a new generation of treatments for cancer and inherited diseases. In parallel, Basecamp Research secured an investment from NVentures (NVIDIA’s venture capital arm) in its pre-Series C round following years of close technical collaboration, which will help the company to accelerate its research and development efforts.

“We believe we are at the start of a major expansion of what’s possible for patients with cancer and genetic disease,” said John Finn, Chief Scientific Officer at Basecamp Research. “By using AI to design the therapeutic enzyme, we hope to accelerate the development of cures for thousands of untreatable diseases, potentially transforming millions of lives.”

Programmable Gene Insertion

Programmable gene insertion – placing large therapeutic DNA sequences at precise locations in the human genome – has been a central goal in genetic medicine for decades. Existing CRISPR-based approaches can only make small edits and must damage DNA to do so, limiting where and how they can be used. Basecamp Research is the first to demonstrate that AI can design enzymes capable of performing large gene insertion at defined sites in the human genome, opening a long-sought path toward programmable therapies.

Basecamp Research’s AI-Programmable Gene Insertion (aiPGI™) platform is powered by EDEN, a new family of evolutionary AI models developed with NVIDIA, trained on BaseData™, the company’s proprietary genomics dataset – the largest of its kind. The models learn the language of DNA and patterns of evolution, allowing the algorithms to design new, programmable therapies for cancer and genetic disease.

In lab results published today in a paper co-authored by NVIDIA, Microsoft and leading academics, [link], the EDEN models designed multiple active insertion proteins for 100% of tested disease-relevant target sites in the human genome, requiring only the genomic target site as a prompt and marking a significant step forward in AI model capability.

Basecamp Research has already demonstrated insertion at over 10,000 disease-related locations in the human genome, including therapeutically relevant integration of cancer-fighting DNA into primary human T cells at novel safe-harbour sites. This produced CAR-T cells that show strong killing of cancer cells, showing over 90% tumour-cell clearance in laboratory assays.

AI-Designed Molecules To Fight “Superbugs”

In another key frontier therapeutic design task targeting the global drug-resistance crisis, the same model proved its versatility by designing a focused library of novel antimicrobial peptides (AMPs) – small proteins with the potential to kill harmful bacteria – with 97% of candidates demonstrating confirmed activity in laboratory tests. In a collaboration with University of Pennsylvania scientists led by Prof. César de la Fuente, the top-performing AMPs showed high potency against critical-priority, multidrug-resistant pathogens, offering a powerful new tool in the fight against dangerous “superbugs.”

Breakthrough powered by unique data & frontier AI models

The EDEN models that power aiPGI™ were trained on over 10 trillion tokens of evolutionary DNA from more than one million newly-discovered species. This data was collected over five years from over 150 locations across 28 countries and five continents as part of a novel data collection strategy pioneered by the company, published in June 2025.

The largest EDEN model was trained on 1.95×1024 FLOPS of compute on a cluster of 1,008 NVIDIA Hopper GPUs and accelerated with libraries from NVIDIA BioNeMo, making it comparable in scale to GPT-4 class models and placing it among the most computationally intensive biological models ever reported.

Therapeutic assets in development

These capabilities underpin Basecamp Research’s emerging pipeline of cell and gene therapies, opening the path to treatments that are more precise, predictable and personalised than those available today. The company’s goal is to develop potentially curative therapies across a range of cancer and genetic disease indications, powered by continued improvements to BaseData™, the EDEN models and aiPGI™.

About Basecamp Research
Basecamp Research is dedicated to solving major challenges in the life sciences by exploring Beyond Known Biology™. The company builds frontier AI models using BaseData, the world’s largest ethically-sourced and globally representative biological dataset. Basecamp Research collects and curates its own biological data through partnerships with more than 152 organizations in 28 countries, giving its AI access to genetic diversity that doesn’t exist for models trained on public database sources. This allows Basecamp Research to design novel protein sequences and biological systems that can accelerate therapeutic research and development.

Basecamp Research partners with biopharma companies and academic institutions worldwide, and its work has been recognized with honors including Fast Company’s Top 10 Most Innovative Companies in Biotech and the FT-backed Sifted AI100 list of Europe’s leading AI startups. Learn more at basecamp-research.com.

BaseData™, Beyond Known Biology™, EDEN-GLM™ and aiPGI™ are brand names and technologies of Basecamp Research.

Relativity Launches aiR for Case Strategy, Bringing Generative AI to Case Intelligence

News Summary:

  • Relativity’s generative AI case intelligence solution, aiR for Case Strategy, launched for general availability today.
  • aiR for Case Strategy extracts key facts from evidence and organizes them into clear timelines, summaries and draft work product, empowering lawyers and litigation professionals to construct the story of their case or investigation with greater speed, confidence and collaboration.
  • Early users have unlocked significant value, surfacing key insights sooner, pulling facts together up to 70% faster and freeing thousands of hours of attorney time for high-impact work.

CHICAGO, Jan. 12, 2026 /PRNewswire/ — Relativity, a legal data intelligence company, today announced the general availability of its generative AI-powered case intelligence solution, Relativity aiR for Case Strategy. Designed with lawyers and litigation professionals in mind, aiR for Case Strategy makes it faster and simpler to develop case narratives, enabling users to auto-extract facts, visualize fact chronologies, accelerate deposition preparation, and create document, witness and transcript summaries.

Relativity
Relativity

“Generative AI is redefining what’s possible in case preparation, empowering legal teams to move from information to insight with greater speed and precision than ever before,” said Phil Saunders, CEO of Relativity. “We’re committed to expanding our case intelligence capabilities because giving our partners and customers a clearer, more complete understanding of their matters sooner enables them to focus on serving their clients, creating greater impact and building narratives that ultimately advance justice.”

Legal teams working across complex disputes often face pressure to understand the facts and issues earlier in the life cycle of a matter. aiR for Case Strategy helps establish a clear factual foundation by revealing key events, illuminating gaps in evidence and highlighting the relationships among people, documents and testimony. This level of context is especially important in disputes and litigation, effectively enabling stronger strategic planning and more confident preparation for witness meetings, interviews and depositions.

Elevating strategic casework from data to decision-making

More than 50 customers have tested aiR for Case Strategy and extracted approximately 600,000 facts through Relativity’s limited general availability program. These early adopters achieved time savings, cost efficiencies, improved collaboration and increased scalability. Tasks that once took hours—sifting through emails, chats and contracts to extract facts, build chronologies and draft summaries—now take minutes. From the outset of a matter, users can uncover the story in their data, shape a case narrative and determine how they want to argue the matter.

“With aiR for Case Strategy, we can see the story behind the evidence much earlier in the process. It helps extract and organize facts into timelines so our teams can quickly turn information into actionable insights,” said Michael Song, Head of GTDocs at Gilbert + Tobin. “That allows our lawyers to spend more time shaping strategy, refining narratives and anticipating challenges, freeing them to focus on the parts of a case that drive the greatest impact.”

Timeline visualizations make it easy to identify gaps or blind spots in the data, helping teams build a complete picture of events. The solution also generates holistic witness summaries that give users a clear view of each key player and support critical decisions about whether a deposition is warranted. Additionally, the solution provides a rich set of interview questions grounded in both the documents and underlying facts, enabling teams to effectively probe each individual’s role in the matter. 

“aiR for Case Strategy dramatically reduces the manual work of extracting facts and building useful timelines in Relativity,” said Martha Louks, Managing Director, Discovery Technology Services, McDermott Will & Emery. “It offers a novel way to eliminate tedious work and allow attorneys to focus on case analysis and strategy.”

Accelerating insight across complex, fast-paced matters

Relativity partner Page One, Inc., used aiR for Case Strategy to support its law firm client on a fast-paced financial services case where large volumes of lengthy deposition transcripts were creating significant pressure on the team. Using the solution to summarize and review 32 transcripts—each 200 to 300-plus pages—the team quickly identified and organized the most important information 70% faster.

“aiR for Case Strategy exceeded expectations by proving not just that it worked, but that it was repeatable, defensible and intuitive,” said Andrew Milauskas, Chief Operating Officer of Page One, Inc. “We went from spending hours per transcript to extracting key facts within minutes. Our confidence grew quickly once we saw that aiR for Case Strategy consistently surfaced the same core insights we would have found manually.”

Transcripts are central to litigation strategy, from depositions to hearings and trials. With aiR for Case Strategy, legal teams can unlock greater clarity from their transcripts through advanced automation and collaboration features. The solution enables users to automatically generate transcript summaries, collaboratively mark up and annotate testimony, and designate key excerpts for trial preparation and presentation. These enhanced capabilities accelerate credibility assessments and empower teams to plot next steps with confidence.

For litigation support professionals, transcript features introduce multi-sync video deposition capabilities, a streamlined workflow for importing depositions and associated files, and exhibit-linking tools that make transcript management more efficient and easier to navigate.

Breaking down silos to build cohesive case stories

Within RelativityOne, aiR for Case Strategy serves as a centralized hub that enables case teams to work from a shared repository of key case intelligence. Teams can move directly from document review into crafting their strategic case story and preparing for investigations, witness examinations, depositions and trial all within one secure, collaborative environment.

“What we’re seeing now with generative AI tools is tighter overlap across teams, reviewers, case teams, and partners working from the same pool of insights,” said Michael Frankel, Counsel at Troutman Pepper Locke. “The silos are breaking down, and everyone can contribute to building the narrative earlier.”

aiR for Case Strategy is currently available in the U.S., the U.K., Australia, Canada, Germany, Switzerland, the Netherlands, Ireland, the UAE, Brazil, South Africa, India, Japan, South Korea, Singapore and Hong Kong, with additional markets to be added over time. The solution is projected to launch in RelativityOne Government in the first half of 2026. To learn more about aiR for Case Strategy, join Relativity on Feb. 19 at 12 p.m. CT for a webinar that walks through how AI is reshaping case strategy to get to the heart of a case faster.

About Relativity
Relativity is a leading legal data intelligence company that builds technology to help users organize data, discover the truth, and act on it. Its extensible, AI-powered cloud platform, RelativityOne, transforms complex data into actionable insights at massive scale for litigation, investigations, regulatory inquiries, data breach responses, and other legal use cases. The world’s largest law firms and corporations, government agencies, and a robust network of channel partners rely on Relativity’s legal AI software to securely surface and manage the most relevant and impactful information in their matters. The company also expands access to technology by providing its platform at no cost to academic institutions through its Relativity Academic program and to organizations supporting pro bono legal work through its Justice for Change initiative.

Contact:
pr@relativity.com

HCLTech to partner with The Magnum Ice Cream Company to modernize its digital foundation

NOIDA, India, Jan. 12, 2026 /PRNewswire/ — HCLTech (NSE: HCLTECH.NS) (BSE: HCLTECH.BO), a leading global technology company, has entered into a multi-year partnership to design, build and manage a future-ready IT infrastructure for The Magnum Ice Cream Company (TMICC), the world’s largest ice cream company. In the coming years, HCLTech will deploy its AI Force platform to embed AI across TMICC’s digital infrastructure.     

HCLTech’s solutions integrate predictive analytics, improve business process observability and keep user experience at the heart of its clients operating model to deliver scalable, resilient IT operations around across the globe. Central to the partnership with TMICC is the evolution from AIOps to a NoOps operating model, enabling zero-touch automation and agentic solutions for fully autonomous IT operations.

“As The Magnum Ice Cream Company advances as an independent listed ice cream company, we are infusing intelligence into every layer of our digital foundation. Our partnership with HCLTech is instrumental in building a secure, future-ready infrastructure. Together, we are unlocking advanced AI capabilities that will redefine operational excellence and elevate the experiences we deliver,” said Mark O’Brien, Chief Technology Officer, The Magnum Ice Cream Company.

The new partnership demonstrates HCLTech’s innovation, agility and operational excellence within the consumer-packaged goods industry, driving technology-led transformation and enhancing customer experience. HCLTech’s proven methodology will ensure TMICC can navigate a seamless Transition Service Agreement (TSA) exit from Unilever and establish a greenfield IT infrastructure to build an AI-powered digital ice cream future.

“This partnership reinforces HCLTech’s leadership in driving complex, global transformations backed by deep domain expertise. We look forward to contributing to TMICC’s growth vision and strategy with the best of technology and global talent,” added C Vijayakumar, CEO & Managing Director, HCLTech.

About HCLTech

HCLTech is a global technology company, home to more than 226,300 people across 60 countries, delivering industry-leading capabilities centered around AI, digital, engineering, cloud and software, powered by a broad portfolio of technology services and products. We work with clients across all major verticals, providing industry solutions for Financial Services, Manufacturing, Life Sciences and Healthcare, High Tech, Semiconductor, Telecom and Media, Retail and CPG, Mobility and Public Services. Consolidated revenues as of 12 months ending December 2025 totaled $14.5 billion. To learn how we can supercharge progress for you, visit hcltech.com.

About The Magnum Ice Cream Company

The Magnum Ice Cream Company is the world’s largest ice cream company. With an unrivalled portfolio of brands including global power brands Magnum, Ben & Jerry’s, Wall’s and Cornetto, and with a global fleet of 3 million freezers, our products are available in over 80 countries. The company generated €7.9 billion in revenue in 2024. For more information, visit The Magnum Ice Cream Company website.

For more information, please contact:
HCLTech 

Nitin Shukla, India
nitin-shukla@hcltech.com

Meredith Bucaro, Americas
meredith-bucaro@hcltech.com

Elka Ghudial, EMEA
elka.ghudial@hcltech.com

James Galvin, APAC
james.galvin@hcltech.com

The Magnum Ice Cream Company
media-relations-tmicc@magnumicecream.com 

 

 

Hang Lung Enters the Next Phase in Its Sustainability Journey with Ambitious New Targets

New targets outlined for 2030 following the successful conclusion of the 25×25 sustainability targets


HONG KONG SAR and SHANGHAI, CHINA – Media OutReach Newswire – 12 January 2026 – Hang Lung Properties Limited (SEHK stock code: 00101) (“Hang Lung” or the “Company”) today announces a new phase in its sustainability journey, unveiling 20 refreshed 2030 targets that build on its success in achieving its 25 x 25 Sustainability Targets.

EN.PNG

Launched in 2021, the 25 x 25 targets defined Hang Lung’s agenda to the end of 2025 across four priorities: Climate Resilience, Resource Management, Wellbeing, and Sustainable Transactions. The Company has achieved its earlier ambitions, and exceeded targets related to greenhouse gas emissions reduction, renewable energy, and energy efficiency. Establishing such a concrete and robust set of targets also helped the Company develop practices in sustainability innovation and continual improvement.

Building on this success, now with expanded data, greater organizational maturity, and heightened ambition, Hang Lung’s refreshed 2030 targets reflect its position as an industry leader in sustainability.

The 20 targets for 2030 continue to be organized under the four priorities that define Hang Lung’s approach to sustainability, including the below highlights:

  • Climate Resilience: Among the first real estate companies in Asia to have near- and long-term targets fully aligned with the Science Based Target initiative’s Buildings Criteria and its emission reduction pathway (1.5°C). Also, Hang Lung is the first real estate company in Asia to establish a Climate Value-at-Risk target.
  • Resource Management: The first real estate company in Asia to formulate a target for biodiversity net gain (10%) on all new development projects and major renovations, supporting urban ecosystems and enhancing green spaces.
  • Wellbeing: Generate at least HK$40 million in social value through community investments.
  • Sustainable Transactions: Collaborate with tenants representing 25% of our leased floor area through our sustainability partnerships program.

Collaboration across the value chain remains central to Hang Lung’s approach, extending beyond traditional metrics. Hang Lung aims to partner with suppliers and tenants through quantifiable targets to drive progress upstream and downstream. In addition, the Company is committed to supporting innovation in standards development to facilitate impactful sustainability initiatives across sectors and jurisdictions.

Mr. Adriel Chan, Chair of Hang Lung Properties and Chair of the Sustainability Steering Committee, commented: “We are excited to embark on this next phase of our sustainability journey, reflecting Hang Lung’s growing role not just as a leader in sustainability action, but also in sustainability thought leadership. By working closely with partners across our value chain, we are confident that we can deliver on these commitments and continue to foster excellence in sustainable development in Asia.”

Mr. John Haffner, Deputy Director – Sustainability, added: “Over the past several years, we have seen how ambitious targets focus our efforts and help develop a culture of innovation. Building on our achievements and lessons learned, our 2030 targets are sharper and more data-driven, and will help us achieve greater impact in our communities.”

Full details of the 25 x 25 wrap-up and the new 2030 targets will be shared in Hang Lung’s 2025 Sustainability Report to be released in March. The report will provide further insights into the Company’s achievements, lessons learned, and emerging plans to support the refreshed 2030 targets, inviting partners and the wider public to join forces in shaping a sustainable future.

Appendix
Overview of 2030 Sustainability Goals and Targets

Priority 2030 Goals 2030 Targets
Climate Resilience

Reduce carbon footprint in line with science and adapt to a changing climate

1. In-use operational emissions: 56.1% per m2 reduction in scope 1, 2 and 3 in-use operational GHG emissions of owned and leased buildings from a 2023 base year.
2. Upfront embodied emissions: 42% reduction in upfront embodied emissions from a 2023 base year.
3. Renewable electricity: 70% of our landlord’s electricity consumption across the portfolio provided by renewable electricity.
4. Adaptation: 10% reduction in our Climate Value-at-Risk compared to the absence of implemented adaptation measures.
Resource Management

Drive efficient and circular use of natural resources and help regenerate nature

5. Energy Use Intensity: 10% reduction in the landlord’s energy use intensity from a 2023 base year.
6. Operational Waste: 35% recycling of municipal solid waste generated from operating properties.
7. Construction Waste: 90% recycling of construction waste generated from construction sites.
8. Water: 8% reduction in freshwater intensity from a 2023 base year.
9. Biodiversity: 10% biodiversity net gain on all new development projects and major renovations with landscape renovation.
Wellbeing

Foster safe, inclusive and healthy spaces that enhance quality of life for all stakeholders

10. Health and safety: Maintain zero work-related fatalities, serious injuries, and occupational diseases for employees and contractors. Maintain a Lost Time Injury Rate of 1.5 or below for employees and contractors.
11. Indoor air quality: Maintain, more than 90% of the time, PM2.5, TVOC and CO2 levels below levels defined in the RESET Air standard.
12. Employee engagement: Maintain an employee engagement survey rating greater than or equal to the 75th percentile.
13. Diversity: At least 5% of our workforce across the portfolio is comprised of people from diverse backgrounds.*
14. Diversity: Maintain Female-to-Male pay ratio of 1:1; maintain gender balance in management positions.
15. Social impact: Create at least HK$40 million in social value through our community investments.
Sustainable Transactions

Collaborate with key stakeholders across our value chain to advance our sustainability priorities

16. Tenant electricity intensity: Benchmarking provided to 100% of tenants across the Chinese Mainland portfolio and work with tenants towards a 10% reduction in their electricity intensity from a 2023 base year.
17. Tenants: Tenants representing 25% of our leased floor area in applicable Chinese Mainland and Hong Kong properties participate in our tenant sustainability partnerships program.
18. Suppliers: Regularly conduct ESG risk screening for 100% of active suppliers and provide ESG assessments for suppliers covering 50% of spending.
19. Procurement: 15% of spending on operational procurement qualifies as sustainable procurement.
20. Standards development: Undertake at least three innovative initiatives in standards development to help accelerate learning and sustainability impact.

* Our definition of diverse background includes people with disabilities and ethnic minorities.

Hashtag: #HangLungProperties

The issuer is solely responsible for the content of this announcement.

About Hang Lung Properties

Hang Lung Properties Limited (SEHK stock code: 00101) creates compelling spaces that enrich lives. Headquartered in Hong Kong and Shanghai, the Company manages a portfolio of over 3.5 million square meters of retail, office, residential, and hotel properties across Hong Kong and mainland China.
The Company’s diverse portfolio in Hong Kong includes office towers and malls in prime districts, as well as luxury residential developments in prestigious areas. In mainland China, under the signature “66” brand, the Company’s mixed-use and retail developments are regarded as premium landmarks, strategically located in the hearts of key cities of Shanghai, Shenyang, Jinan, Wuxi, Tianjin, Dalian, Kunming, Wuhan, and Hangzhou.
The Company is recognized for pioneering sustainability in the real estate industry, with an MSCI ESG rating of AA and inclusion on CDP “A List” for Climate Change. The Company powers 80% of its operating properties in the Mainland with renewable energy, with a net zero commitment by 2050.
At Hang Lung Properties – We Do It Well.
For more information, please visit .

Diabolocom Receives Frost & Sullivan’s 2026 European Technology Innovation Leadership for Excellence in AI-Driven Customer Experience Platforms

Recognition highlights Diabolocom’s innovation leadership, sovereign cloud strategy, and customer-centric approach to secure, compliant, and sustainable software & AI for Customer Experience

SAN ANTONIO, Jan. 12, 2026 /PRNewswire/ — Frost & Sullivan is pleased to announce that Diabolocom has been awarded the 2026 European Technology Innovation Leadership in the Customer Experience Platform industry for its outstanding achievements in AI-driven innovation, sustainable infrastructure design, and strategy execution. This recognition underscores Diabolocom’s ability to deliver measurable customer impact while strengthening its competitive position in a rapidly evolving CX market.

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: business impact and technology leverage. Diabolocom excels in both, demonstrating a strong alignment between long-term vision, regulatory requirements, and market demand, while executing with consistency, efficiency, and scale.

“Through this integrated approach, Diabolocom demonstrates that sustainability and innovation are mutually reinforcing forces. Its dedication to responsible infrastructure, transparent governance, and efficient AI design allows customers to adopt cutting-edge CX technologies that are secure, compliant, and environmentally sound,” said Bernardin Arnason, Industry Director, Growth Opportunity Analytics, Frost & Sullivan.

Guided by a long-term growth strategy centered on proprietary, independent R&D, Diabolocom continues to adapt and lead amid complex macroeconomic and regulatory conditions, developing its own AI-first platform designed to address the real business needs of customer service and sales teams. With 20 years of experience in the industry, Diabolocom has successfully brought AI capabilities to the international market, grounded in concrete use cases — from Agent Assist, which supports agents in real time as they handle customer inquiries, to Augmented Quality Monitoring, which analyzes conversations and delivers deep, actionable insights.

Innovation remains central to Diabolocom’s approach. Its AI-enabled customer experience platform and CCaaS (Contact Center as a Service) solutions support omnichannel engagement across voice and digital channels, delivering scalability, interoperability, and performance without compromising efficiency or governance. By combining purpose-built large and small language models with a cloud architecture, the company enables enterprises to integrate AI into workflows at their own pace while maintaining control over data residency, costs, and operational resilience. Diabolocom stands out for its ability to innovate across the entire production chain by developing an omnichannel interaction management platform with native AI capabilities while delivering operator services and cloud hosting.

“Diabolocom’s strength lies in full ownership of the CX technology stack. By controlling our software, AI, and infrastructure end-to-end, we eliminate dependency risk and deliver solutions that are inherently more reliable, secure, and adaptable to each customer’s operational and regulatory requirements. For our customers, this means working with a single, trusted partner that helps them to move confidently into the next chapter of CX, with proven results,” says Frédéric Durand, Founder & CEO at Diabolocom.

Diabolocom’s unwavering commitment to customer experience further reinforces its leadership position. The company empowers organizations with flexible deployment models, advanced self-service capabilities, and hands-on enablement that accelerate adoption and long-term value creation. Its focus on localized support, partner-led delivery, and transparent governance has proven critical for enterprises operating in regulated and multilingual environments across.

Frost & Sullivan commends Diabolocom for setting a high benchmark in technology innovation, execution excellence, and market responsiveness. The company’s vision, sovereign infrastructure, and sustainability-first AI strategy are shaping the future of customer experience platforms and enabling enterprises to achieve secure, compliant, and environmentally responsible transformation at scale.

Each year, Frost & Sullivan presents the Technology Innovation Leadership recognition to a company that demonstrates outstanding technology development and implementation, resulting in measurable improvements in performance, customer value, and competitive positioning. The recognition highlights organizations that are redefining their industries through forward-looking innovation and growth excellence.

Frost & Sullivan Best Practices Recognition

Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.
Contact us: Start the discussion.

Contact:
Ashley Shreve
E: ashley.weinkauf@frost.com 

About Diabolocom

Diabolocom is the leading European provider of AI-first cloud-based contact center (CCaaS) and customer experience (CX) solutions that help organizations deliver seamless, personalized customer experiences. The platform combines proprietary AI technology, native telecom infrastructure, and deep CRM integrations to automate tasks, elevate data quality, and empower agents across all touchpoints.

Trusted by 400+ clients and deployed in 60+ countries, Diabolocom bridges the agility of SaaS innovation with carrier-grade voice performance. With offices worldwide and more than two decades of experience, the company advances customer loyalty and growth through sovereign, intelligent, and scalable communication technology.

Contact us: marketing@diabolocom.com
Visit our website: www.diabolocom.com/press

NYSE Content Advisory: Pre-Market Update + NYSE Takes Its Bell on the Road to JPMorgan’s Healthcare Event

NEW YORK, Jan. 12, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

 

NYSE Content Advisory: Pre-Market Update + NYSE Takes Its Bell on the Road to JPMorgan’s Healthcare Event

JD Durkin delivers the pre-market update on January 12th

  • Stocks are down Monday morning after the Justice Department opened a criminal investigation into Federal Reserve Chair Jerome Powell. Despite White House pressure to lower interest rates, Powell stated Sunday he will stick to his methodology. Traders had not priced in a rate cut for the Fed’s upcoming meeting.
  • Download the NYSE TV app and tune in to NYSE Live at 9 a.m. ET for coverage from J.P. Morgan’s 44th Annual Healthcare Conference in San Francisco. Kristen Scholer will report from the event, where the Opening Bell rings at the Westin St. Francis on Union Square.
  • After the market opens, Kristen will interview Jeremy Milman, head of J.P. Morgan’s Global Healthcare Investment Banking Group, on key trends shaping 2026 and how the bank supports innovation. The four-day conference hosts 500+ companies and 8,000 attendees.
  • The 28th Annual ICR Conference kicks off in Orlando, drawing 3,000 attendees and leadership teams from 250+ growth companies. Ashley Mastronardi is on-site connecting with NYSE community leaders—watch for those interviews soon on our app.

Opening Bell
JPMorgan Chase (NYSE: JPM) kicks off the 2026 J.P. Morgan Healthcare Conference

Closing Bell
Riskified (NYSE: RSKD) celebrates another successful year with their incredible merchants

Click here to download the NYSE TV App

 

Oriental Culture Holding LTD Announces Special Cash Dividend Plan to Reward Shareholders on Fifth Anniversary of Listing

Nasdaq: OCG

NEW YORK, Jan. 12, 2026 /PRNewswire/ — Oriental Culture Holding LTD (Nasdaq: OCG) announced today that its Board of Directors has approved a special cash dividend plan to celebrate the company’s fifth anniversary of listing on Nasdaq and reward shareholders for their long-term support.

The specific dividend details are as follows:

  • Dividend Type: Special Cash Dividend
  • Eligible Shareholders: Shareholders of record as of January 22, 2026
  • Dividend Amount: US$0.05 per share (based on shares outstanding as of the record date of January 22, 2026)
  • Payment Date: February 9, 2026

OCG CEO Shao Yi stated: “After securing the necessary funds for ongoing operations and development, the company has decided to return a portion of accumulated cash reserves from prior years to shareholders as dividends. This reflects our commitment to rewarding shareholder support and sharing in our growth achievements. This dividend represents our sincere gratitude for shareholders’ five-year partnership. We firmly believe that while actively developing our business, we must also directly reward shareholders to foster long-term value creation.”

This dividend plan was approved by the Board of Directors on January 8, 2026, and its implementation will comply with relevant regulations.

Forward-Looking Statements: This press release contains forward-looking statements. Actual results may differ materially from those expressed or implied due to risks and uncertainties. OCG assumes no obligation to update this information.